Enrich Bio-Tech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 94.41%
- Net Worth -47.16%
- Total Assets -77.81%
About Enrich Bio-Tech India
Enrich Bio-Tech India Private Limited (EBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2004 and has a history of 21 years. Its registered office is in Bangalore 560 069, Karnataka.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Punniamoorthy and Sudha serve as directors at the Company.
Company Details
-
LocationBangalore 560 069, Karnataka
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01122KA2004PTC033281
-
Company No.
033281
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jan 2004
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Enrich Bio-Tech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Punniamoorthy
|
Director | 28-Apr-2015 | Current |
|
Sudha
|
Director | 12-Apr-2016 | Current |
Financial Performance of Enrich Bio-Tech India.
Enrich Bio-Tech India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.41% increase in profit. The company's net worth observed a substantial decline by a decrease of 47.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enrich Bio-Tech India?
In 2019, Enrich Bio-Tech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
K G M Sheltors Private LimitedKannan Punniamoorthy and Sudha are mutual person
-
Pvy Warehouse Private Limited
Kannan Punniamoorthy is a mutual person
-
K G M Warehouse Private Limited
Kannan Punniamoorthy and Sudha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Enrich Bio-Tech India?
Unlock and access historical data on people associated with Enrich Bio-Tech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enrich Bio-Tech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enrich Bio-Tech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
